Living donor liver transplantation for non-alcoholic steatohepatitis: A single center experience

Hepatology Research

Volumn 44, Issue 10, 2014, Pages E3-E10

  Tanaka, Tomohiro ^a   Sugawara, Yasuhiko ^b   Tamura, Sumihito ^b   Kaneko, Junichi ^b   Takazawa, Yutaka ^b   Aoki, Taku ^b   Hasegawa, Kiyoshi ^b   Sakamoto, Yoshihiro ^b   Yamashiki, Noriyo ^a   Kokudo, Norihiro ^b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Living donor liver transplantation; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMORBIDITY; DRUG DOSE REDUCTION; ECHOGRAPHY; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; JAPANESE (PEOPLE); LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; RECURRENT DISEASE; SURVIVAL RATE;

EID: 84907866408     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12200     Document Type: Article

References (35)

1. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-350.
2. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003; 38: 954-961.
3. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
4. Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl 2006; 12: 523-534.
5. Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009; 51: 371-379.
6. Bugianesi E, Leone N, Vanni E etal. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140.
7. Malik SM, Gupte PA, de Vera ME, Ahmad J. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Clin Gastroenterol Hepatol 2009; 7: 800-806.
8. Afzali A, Berry K, Ioannou GN. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl 2012; 18: 29-37.
9. Agopian VG, Kaldas FM, Hong JC etal. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg 2012; 256: 624-633.
10. Sreekumar R, Rosado B, Rasmussen D, Charlton M. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 2003; 38: 244-251.
11. Romeo S, Kozlitina J, Xing C etal. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-1465.
12. Carulli L, Canedi I, Rondinella S etal. Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. Dig Liver Dis 2009; 41: 823-828.
13. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52: 894-903.
14. Petersen KF, Dufour S, Hariri A etal. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010; 362: 1082-1089.
15. Kawaguchi T, Sumida Y, Umemura A etal. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 2012; 7: e38322.
16. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr 2002; 11 (Suppl 8): S732-737.
17. Sugawara Y, Makuuchi M. Right lateral sector graft as a feasible option for partial liver transplantation. Liver Transpl 2004; 10: 1156-1157.
18. Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant 2005; 5: 1694-1703.
19. Matsuo S, Imai E, Horio M etal. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
20. Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kawarasaki H. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transplant 2002; 16: 102-106.
21. Kleiner DE, Brunt EM, Van Natta M etal. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
22. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007; 25: 310-312.
23. Yamashiki N, Sugawara Y, Tamura S etal. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement. Transplantation 2009; 88: 575-581.
24. Koehler E, Watt K, Charlton M. Fatty liver and liver transplantation. Clin Liver Dis 2009; 13: 621-630.
25. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-1362.
26. Burke A, Lucey MR. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 2004; 4: 686-693.
27. Okanoue T, Umemura A, Yasui K, Itoh Y. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan. J Gastroenterol Hepatol 2011; 26 (Suppl 1): 153-162.
28. Contos MJ, Cales W, Sterling RK etal. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001; 7: 363-373.
29. Sanjeevi A, Lyden E, Sunderman B, Weseman R, Ashwathnarayan R, Mukherjee S. Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients. Transplant Proc 2003; 35: 2977-2980.
30. Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl 2009; 15: 1814-1820.
31. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009; 9: 782-793.
32. Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl 2010; 16: 431-439.
33. Mells G, Neuberger J. Protocol liver allograft biopsies. Transplantation 2008; 85: 1686-1692.
34. Cholongitas E, Tsochatzis E, Goulis J, Burroughs AK. Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review. Transpl Int 2010; 23: 861-870.
35. Rigamonti C, Fraquelli M, Bastiampillai AJ etal. Transient elastography identifies liver recipients with nonviral graft disease after transplantation: a guide for liver biopsy. Liver Transpl 2012; 18: 566-576.